MyFinsight
Home
Blog
About
Back
Income Statement
Atara Biotherapeutics, Inc. (ATRA)
Atara Biotherapeutics, Inc. (ATRA)
source: myfinsight.com
Comprehensive income (loss)
-$4,836K
(-302.60%↓ Y/Y)
Net income (loss)
-$4,834K
(-302.51%↓ Y/Y)
Unrealized gain (loss) on
available-for-sale securities
-$2K
Income (loss) before
provision for (benefit...
-$4,833K
(-302.22%↓ Y/Y)
Provision for (benefit
from) income taxes
$1K
(-66.67%↓ Y/Y)
Income (loss) from
operations
-$4,720K
(-247.64%↓ Y/Y)
Total other income
(expense), net
-$113K
(86.00%↑ Y/Y)
Commercialization revenue
$630K
(-96.42%↓ Y/Y)
Interest income
$78K
(-45.45%↓ Y/Y)
Total costs and
operating expenses
$5,350K
(-62.79%↓ Y/Y)
Interest expense
$191K
(-80.35%↓ Y/Y)
General and
administrative expenses
$3,814K
(-41.45%↓ Y/Y)
Research and development
expenses
$1,345K
(-81.60%↓ Y/Y)
Cost of
commercialization revenue
$191K
(-65.52%↓ Y/Y)
Back